InvestorsHub Logo
Followers 112
Posts 8712
Boards Moderated 0
Alias Born 06/05/2011

Re: None

Saturday, 11/13/2021 1:08:12 AM

Saturday, November 13, 2021 1:08:12 AM

Post# of 118384
9. Intellectual Property

It is understood that the IP that will be licensed into Canary will originate from Cornell University and specifically from the laboratory of Dr. Shahin Rafii. The final IP will be included in the definitive agreement as an appendix. This IP allows for the creation of patient-derived tumor on vascular nets for in vitro testing of therapeutic agents.

Start at 18:10 to see our guy, Dr. Shahin Rafii.